Upper Respiratory Tract Infection: Clinical Trials

8 trials for Upper Respiratory Tract Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 terminated, 1 unknown. 8 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 38Completed 6, Terminated 1, Unknown 1

Follow Upper Respiratory Tract Infection: new trials by email Literature Review of Upper Respiratory Tract Infection trials Research Report on Upper Respiratory Tract Infection

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI
A. Paniculata, A. Chilensis, A. Paniculata and A. Chilensis - Upper Respiratory Tract Infection
Phase 3CompletedVedic Lifesciences Pvt. Ltd.2252021-03-202022-05-10
Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life
Vitamin D3, Placebo - Acute Bronchitis, Upper Respiratory Tract Infection
Phase 3CompletedHospital Universitari Vall d'Hebron Research Institute2002013-11-012017-03-22
Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu
Paracetamol (500 mg)/dimethindene maleate (1 mg)/ phenylephrine hydrochloride (10 mg) tablets, Paracetamol (500 mg) tablets - Upper Respiratory Tract Infection, Nasal Congestion
Phase 3CompletedNovartis3412013-07-012017-03-03
A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection
Oseltamivir, Zanamivir, Placebo of Oseltamivir - Upper Respiratory Tract Infection, Influenza
Phase 3TerminatedChinese University of Hong Kong42009-10-012011-04-11
Combined Vitamins and Minerals Decrease Incidence of Upper Respiratory Tract Infections in Older Persons
daily multi micronutrient supplement, Placebo - Upper Respiratory Tract Infection
Phase 3CompletedTrisakti University2702008-08-012011-12-06
Oseltamivir Randomised Controlled Efficacy Trial
Oseltamivir, Placebo - Influenza, Pneumonia
Phase 3CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh11902008-05-012018-06-06
Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children: a Randomised, Double-blind, Placebo-controlled Study
Muntelukast, Placebo - Upper Respiratory Tract Infection
Phase 3UnknownAssaf-Harofeh Medical Center5002007-11-012010-03-17
A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis
Azithromycin SR - Upper Respiratory Tract Infection
Phase 3CompletedPfizer992006-11-012008-05-16

Narrower conditions

Respiratory Tract Infections (8)  ·  Influenza, Human (2)  ·  Bronchiolitis (1)  ·  Bronchitis (1)  ·  Common Cold (1)  ·  Nasal Obstruction (1)  ·  Otitis Media (1)  ·  Pneumonia (1)  ·  Rhinorrhea (1)  ·  Sneezing (1)

Broader conditions

Infections (8)  ·  Respiratory Tract Diseases (8)  ·  RNA Virus Infections (3)  ·  Virus Diseases (3)  ·  Bronchial Diseases (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Obstructive (2)  ·  Orthomyxoviridae Infections (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Airway Obstruction (1)  ·  Bronchitis (1)  ·  Ear Diseases (1)  ·  Nose Diseases (1)  ·  Otitis (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Oseltamivir (2)  ·  Acetaminophen (1)  ·  Andrographis paniculata extract (1)  ·  Cholecalciferol (1)  ·  Cold Temperature (1)  ·  Dimethindene (1)  ·  Phenylephrine (1)  ·  Vitamins (1)  ·  Zanamivir (1)  ·  Zinc (1)  ·  microcrystalline cellulose (1)  ·  montelukast (1)

Sponsors

Assaf-Harofeh Medical Center (1)  ·  Chinese University of Hong Kong (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (1)  ·  Novartis (1)  ·  Pfizer (1)  ·  Trisakti University (1)  ·  Vedic Lifesciences Pvt. Ltd. (1)

Countries

Bangladesh (1)  ·  Brazil (1)  ·  China (1)  ·  Hong Kong (1)  ·  India (1)  ·  Indonesia (1)  ·  Israel (1)  ·  Japan (1)  ·  Spain (1)

Top investigators

Antonio Moreno, MD, PhD (1)  ·  Eran Kozer, MD (1)  ·  Mati Berkovitch, MD (1)  ·  Rina K Kusumaratna, Dr (1)  ·  W. Abdullah Brooks, MD, MPH (1)

Results publications

PMID 24268590, PMID 25788164

NIH funding

U01IP000127 (1)